
Journal of Medicinal Chemistry p. 1896 - 1907 (1991)
Update date:2022-09-26
Topics:
Gazit, Aviv
Osherov, Nir
Posner, Israel
Yaish, Pnina
Poradosu, Enrique
et al.
We have previously described a novel series of low molecular weight protein tyrosine kinase inhibitors which we named tyrphostins.The characteristic active pharmacophore of these compounds was the hydroxy-cis-benzylidenemalonitrile moiety.In this article we describe three novel groups of tyrphostins: (i) one group has the phenolic moiety of the cis-benzylidenemalononitrile replaced either with other substituted benzenes or with heteroaromatic rings, (ii) another is a series of conformationally constrained derivatives of hydroxy-cis-benzylidenemalononitriles in which the malononitrile moiety is fixed relative to the aromatic ring, and (iii) two groups of compounds in which the position trans to the benzenemalononitrile has been substituted by ketones and amides.Among the novel tyrphostins examined we found inhibitors which discriminate between the highly homologous EGF receptor kinase (HER1) and ErbB2/neu kinase (HER2).These findings may lead to selective tyrosine kinase blockers for the treatment of diseases in which ErbB2/neu is involved.
View MoreContact:86-21 60347964
Address:No.1304, West Meilong Road, Minhang District, Shanghai, China
website:http://www.angchenchem.com
Contact:+86-510-88302099 82327577
Address:Rm. 404/405, Floor 4th, No. 983 FengXiang Road, Wuxi, China
Shanghai Kefu Chemical Co.,Ltd.
Contact:+86-21-34616196
Address:Room601-602, Xuhui Business Building, No.168, Yude Road, Shanghai
Contact:+1-284-4950244
Address:Box 3069, Road Town, Tortola, British Virgin Islands
website:http://www.oceanchem-group.com
Contact:86-536-8596048
Address:9th floor,Building B future Plaza, No.88.Fenghuang Street,Weifang,Shandong,China
Doi:10.1021/ja00010a036
(1991)Doi:10.1021/ja00009a029
(1991)Doi:10.1016/j.tet.2011.08.006
(2011)Doi:10.1021/jm200815w
(2011)Doi:10.1021/om200729x
(2011)Doi:10.1021/jo00011a030
(1991)